OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Accelerating the understanding of cancer biology through the lens of genomics
Dongfang Wang, Baolin Liu, Zemin Zhang
Cell (2023) Vol. 186, Iss. 8, pp. 1755-1771
Closed Access | Times Cited: 43
Dongfang Wang, Baolin Liu, Zemin Zhang
Cell (2023) Vol. 186, Iss. 8, pp. 1755-1771
Closed Access | Times Cited: 43
Showing 26-50 of 43 citing articles:
Construction of a Novel Disulfidptosis-Related lncRNA Prognostic Signature in Pancreatic Cancer
Faliang Xing, Yi Qin, Jin Xu, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2396-2414
Closed Access | Times Cited: 5
Faliang Xing, Yi Qin, Jin Xu, et al.
Molecular Biotechnology (2023) Vol. 66, Iss. 9, pp. 2396-2414
Closed Access | Times Cited: 5
Ultrasound‐Activated Piezocatalyst Triggers Sulfate Radical Production for Augmented Oxidative Tumor Suppression
Mengying Hua, Ruohui Wu, Wenying Chen, et al.
Small Structures (2023) Vol. 5, Iss. 4
Open Access | Times Cited: 4
Mengying Hua, Ruohui Wu, Wenying Chen, et al.
Small Structures (2023) Vol. 5, Iss. 4
Open Access | Times Cited: 4
Generalizable transcriptome-based tumor malignant level evaluation and molecular subtyping towards precision oncology
Dingxue Hu, Ziteng Zhang, Xiaoyi Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Dingxue Hu, Ziteng Zhang, Xiaoyi Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Defining cellular determinants of resistance to PD-1 pathway blockade in non-small-cell lung cancer
Baolin Liu, Kaichao Feng, Kezhuo Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Baolin Liu, Kaichao Feng, Kezhuo Yu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Small RNAs in Cancer Therapy
Yufei Pan, Quanxin Wang, Yuan Ma
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Yufei Pan, Quanxin Wang, Yuan Ma
Interdisciplinary cancer research (2024)
Closed Access | Times Cited: 1
Unveiling the therapeutic promise: exploring Lysophosphatidic Acid (LPA) signaling in malignant bone tumors for novel cancer treatments
Yichen Qi, Yukai Wang, Jinping Yuan, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Yichen Qi, Yukai Wang, Jinping Yuan, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
HMGB2 drives tumor progression and shapes the immunosuppressive microenvironment in hepatocellular carcinoma: insights from multi-omics analysis
Yanzhu Chen, Zhishang Meng, Zuo‐Lin Xiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Yanzhu Chen, Zhishang Meng, Zuo‐Lin Xiang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion
Joshua Lee, Elizabeth A. Snell, Julia Brown, et al.
Genome Research (2024) Vol. 34, Iss. 11, pp. 1849-1864
Closed Access | Times Cited: 1
Joshua Lee, Elizabeth A. Snell, Julia Brown, et al.
Genome Research (2024) Vol. 34, Iss. 11, pp. 1849-1864
Closed Access | Times Cited: 1
High-resolution and programmable RNA-IN and RNA-OUT genetic circuit in living mammalian cells
Min Zhang, Xue Zhang, Yong‐Yue Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Min Zhang, Xue Zhang, Yong‐Yue Xu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology (2024) Vol. 51, pp. 102226-102226
Open Access | Times Cited: 1
Sébastien Taurin, Reem Alzahrani, Sahar Aloraibi, et al.
Translational Oncology (2024) Vol. 51, pp. 102226-102226
Open Access | Times Cited: 1
Metastatic brain tumors: from development to cutting‐edge treatment
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Guilong Tanzhu, Liu Chen, Jiaoyang Ning, et al.
MedComm (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 1
Multiorgan locked-state model of chronic diseases and systems pharmacology opportunities
Choong Yong Ung, Cristina Correia, Hu Li, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103825-103825
Open Access | Times Cited: 3
Choong Yong Ung, Cristina Correia, Hu Li, et al.
Drug Discovery Today (2023) Vol. 29, Iss. 1, pp. 103825-103825
Open Access | Times Cited: 3
Long-read RNA sequencing redefines the clear cell renal cell carcinoma transcriptome and reveals novel genes and transcripts associated with disease recurrence and immune evasion
Joshua Lee, Elizabeth A. Snell, Julia Brown, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Joshua Lee, Elizabeth A. Snell, Julia Brown, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Design, docking optimization, and evaluation of biotin-PEG4-1,8-naphthalimide as potent and safety antitumor agent with dual targeting of ferroptosis and DNA
Qi Wang, Simin Liang, Zhi-Chen Mao, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1640-1651
Closed Access
Qi Wang, Simin Liang, Zhi-Chen Mao, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 5, pp. 1640-1651
Closed Access
Machine learning unveils key Redox signatures for enhanced breast Cancer therapy
Tao Wang, Shu Wang, Zhuolin Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Tao Wang, Shu Wang, Zhuolin Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Multi-fusion strategy network-guided cancer subtypes discovering based on multi-omics data
J. Liu, Xiaoguang Xue, Pengbo Wen, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
J. Liu, Xiaoguang Xue, Pengbo Wen, et al.
Frontiers in Genetics (2024) Vol. 15
Open Access
GLN2 as a key biomarker and therapeutic target: evidence from a comprehensive pan-cancer study using molecular, functional, and bioinformatic analyses
Shuang Gao, Lei Zhang, Guoping Sun
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Shuang Gao, Lei Zhang, Guoping Sun
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Collateral lethality: A unique type of synthetic lethality in cancers
Zichen Zhao, Lingling Zhu, Yu Luo, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108755-108755
Closed Access
Zichen Zhao, Lingling Zhu, Yu Luo, et al.
Pharmacology & Therapeutics (2024) Vol. 265, pp. 108755-108755
Closed Access
